AN2 Therapeutics

IPO

Developing Therapies for Rare, Chronic, and Serious Infectious Diseases

AN2 Therapeutics was founded in 2017, is headquartered in Menlo Park, United States, lists 11–50 employees, and has $52.0M in recorded funding across 2 rounds.

Headquarters
Menlo Park
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$52.0M
Last Round
$40.0M Private EquityMar 2026
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

AN2 Therapeutics is a clinical-stage biopharmaceutical company (Nasdaq: ANTX) focused on the discovery, development, and commercialization of novel medicines for rare, chronic, and serious infectious diseases with significant unmet patient need. The founding team has a track record of pairing strategic partnerships and non-dilutive funding to advance global public health programs alongside its core clinical pipeline. AN2 is headquartered in Menlo Park, California.

Summary

AN2 Therapeutics is a Biotech company based in Menlo Park, United States, founded in 2017. It lists 11–50 employees. It has raised $52.0M in total across 2 rounds, most recently a $40.0M Private Equity round in Mar 2026. Investors include Mountain Partners, Coastlands Capital and Commodore Capital.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate EquityMar 2026
$40.0M

Sign up to see all 3 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AN2 Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/an2-therapeutics"><img src="https://indexed.vc/api/badge/company/an2-therapeutics" alt="AN2 Therapeutics on Indexed.vc" width="260" height="76" /></a>